[96a5a0]: / output / allTrials / identified / NCT05001282_identified.json

Download this file

662 lines (662 with data), 28.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
{
"info": {
"nct_id": "NCT05001282",
"official_title": "Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors",
"inclusion_criteria": "Patients must meet the following criteria to enroll in this study:\n\n* Part 1 Documented diagnosis of ovarian cancer, endometrial cancer, colorectal cancer, gastric cancer, gastroesophageal junction cancer, triple negative breast cancer, non-small cell lung cancer, or cholangiocarcinoma\n* Part 2 Ovarian Cancer or Endometrial Cancer\n* No other meaningful life-prolonging therapy option available\n* Must provide archival tumor tissue or a newly obtained tumor biopsy specimen prior to the first dose of ELU001 for folate receptor alpha (FRα) expression analysis. Previous FRα expression test results may be used in certain circumstances\n* Adequate organ function\n* Measurable disease, or in the absence of measurable disease, non-measurable disease as per Response evaluation criteria in solid tumors (RECIST) v1.1\n* Part 1: Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2; Part 2: ECOG performance status of 0 or 1.\n* Recovered from previous surgeries\n* Agree to highly effective contraception, not to get pregnant, or for men, not father a child during study participation\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "Patients who meet any of the following are not eligible to enroll in this study:\n\n* Clinically significant eye disorders\n* Taken any treatments that use the protein folate receptor alpha or FRα to work\n* Taken any other experimental treatments\n* History of significant cardiac issues or other cancers within 3 years.\n* Significant anemia, significant neutropenia, or significant thrombocytopenia (e.g., not enough platelets in your blood - platelets held stop bleeding in your body)\n* Detectable viral load for HIV (human immunodeficiency virus), hepatitis B or C.\n* If you are pregnant.\n* Part 1: Cannot have active autoimmune diseases such as rheumatoid arthritis, SLE (systemic lupus erythematosus), ulcerative colitis, Crohn's Disease, MS (multiple sclerosis), ankylosing spondylitis, thyroiditis that require treatments that suppress your immune system.\n* Part 1: if your cancer has spread to your brain.\n* Part 2: You can have cancer that has spread to your brain but there are exceptions. The cancer in your brain cannot be causing any symptoms, it cannot be larger than 3 cm, there can be no evidence on a scan that shows your brain tissue has shifted from its expected position inside the skull (called \"herniation\") or be bleeding in the skull or brain itself (called \"hemorrhage\").",
"miscellaneous_criteria": "Key"
},
"inclusion_lines": [
{
"line": "* Part 2 Ovarian Cancer or Endometrial Cancer",
"criterions": [
{
"exact_snippets": "Ovarian Cancer",
"criterion": "Ovarian Cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Endometrial Cancer",
"criterion": "Endometrial Cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No other meaningful life-prolonging therapy option available",
"criterions": [
{
"exact_snippets": "No other meaningful life-prolonging therapy option available",
"criterion": "life-prolonging therapy option",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "* Must provide archival tumor tissue or a newly obtained tumor biopsy specimen prior to the first dose of ELU001 for folate receptor alpha (FRα) expression analysis. Previous FRα expression test results may be used in certain circumstances",
"criterions": [
{
"exact_snippets": "Must provide archival tumor tissue or a newly obtained tumor biopsy specimen",
"criterion": "tumor tissue or biopsy specimen",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"exact_snippets": "folate receptor alpha (FRα) expression analysis",
"criterion": "folate receptor alpha (FRα) expression",
"requirements": [
{
"requirement_type": "analysis",
"expected_value": true
}
]
}
]
},
{
"line": "* Adequate organ function",
"criterions": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "adequate"
}
]
}
]
},
{
"line": "* Measurable disease, or in the absence of measurable disease, non-measurable disease as per Response evaluation criteria in solid tumors (RECIST) v1.1",
"criterions": [
{
"exact_snippets": "Measurable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "measurable"
}
]
},
{
"exact_snippets": "absence of measurable disease, non-measurable disease",
"criterion": "disease measurability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "non-measurable"
}
]
}
]
},
{
"line": "* Part 1: Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2; Part 2: ECOG performance status of 0 or 1.",
"criterions": [
{
"exact_snippets": "Part 1: Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1",
"2"
]
}
]
},
{
"exact_snippets": "Part 2: ECOG performance status of 0 or 1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Recovered from previous surgeries",
"criterions": [
{
"exact_snippets": "Recovered from previous surgeries",
"criterion": "recovery from previous surgeries",
"requirements": [
{
"requirement_type": "status",
"expected_value": "recovered"
}
]
}
]
},
{
"line": "* Agree to highly effective contraception, not to get pregnant, or for men, not father a child during study participation",
"criterions": [
{
"exact_snippets": "Agree to highly effective contraception",
"criterion": "contraception",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
},
{
"exact_snippets": "not to get pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "not pregnant"
}
]
},
{
"exact_snippets": "for men, not father a child",
"criterion": "fathering a child",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "not father a child"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Clinically significant eye disorders",
"criterions": [
{
"exact_snippets": "Clinically significant eye disorders",
"criterion": "eye disorders",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* Taken any treatments that use the protein folate receptor alpha or FRα to work",
"criterions": [
{
"exact_snippets": "Taken any treatments that use the protein folate receptor alpha or FRα to work",
"criterion": "treatment using folate receptor alpha",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Taken any other experimental treatments",
"criterions": [
{
"exact_snippets": "Taken any other experimental treatments",
"criterion": "experimental treatments",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* History of significant cardiac issues or other cancers within 3 years.",
"criterions": [
{
"exact_snippets": "History of significant cardiac issues",
"criterion": "cardiac issues",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "significance",
"expected_value": true
}
]
},
{
"exact_snippets": "other cancers within 3 years",
"criterion": "other cancers",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Significant anemia, significant neutropenia, or significant thrombocytopenia (e.g., not enough platelets in your blood - platelets held stop bleeding in your body)",
"criterions": [
{
"exact_snippets": "Significant anemia",
"criterion": "anemia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
},
{
"exact_snippets": "significant neutropenia",
"criterion": "neutropenia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
},
{
"exact_snippets": "significant thrombocytopenia",
"criterion": "thrombocytopenia",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* If you are pregnant.",
"criterions": [
{
"exact_snippets": "If you are pregnant.",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Part 1: Cannot have active autoimmune diseases such as rheumatoid arthritis, SLE (systemic lupus erythematosus), ulcerative colitis, Crohn's Disease, MS (multiple sclerosis), ankylosing spondylitis, thyroiditis that require treatments that suppress your immune system.",
"criterions": [
{
"exact_snippets": "Cannot have active autoimmune diseases such as rheumatoid arthritis, SLE (systemic lupus erythematosus), ulcerative colitis, Crohn's Disease, MS (multiple sclerosis), ankylosing spondylitis, thyroiditis",
"criterion": "active autoimmune diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "require treatments that suppress your immune system",
"criterion": "treatments that suppress immune system",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": false
}
]
}
]
},
{
"line": "* Part 1: if your cancer has spread to your brain.",
"criterions": [
{
"exact_snippets": "cancer has spread to your brain",
"criterion": "cancer metastasis to brain",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "Patients must meet the following criteria to enroll in this study:",
"criterions": []
},
{
"line": "* Part 1 Documented diagnosis of ovarian cancer, endometrial cancer, colorectal cancer, gastric cancer, gastroesophageal junction cancer, triple negative breast cancer, non-small cell lung cancer, or cholangiocarcinoma",
"criterions": [
{
"exact_snippets": "Documented diagnosis of ovarian cancer",
"criterion": "ovarian cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Documented diagnosis of endometrial cancer",
"criterion": "endometrial cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Documented diagnosis of colorectal cancer",
"criterion": "colorectal cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Documented diagnosis of gastric cancer",
"criterion": "gastric cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Documented diagnosis of gastroesophageal junction cancer",
"criterion": "gastroesophageal junction cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Documented diagnosis of triple negative breast cancer",
"criterion": "triple negative breast cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Documented diagnosis of non-small cell lung cancer",
"criterion": "non-small cell lung cancer",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "Documented diagnosis of cholangiocarcinoma",
"criterion": "cholangiocarcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "Key",
"criterions": [
{
"exact_snippets": "Tissue from tumor must be available",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"exact_snippets": "Tissue from tumor ... > 2 cm in diameter.",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "cm"
}
}
]
}
]
}
],
"failed_exclusion": [
{
"line": "Patients who meet any of the following are not eligible to enroll in this study:",
"criterions": []
},
{
"line": "* Detectable viral load for HIV (human immunodeficiency virus), hepatitis B or C.",
"criterions": [
{
"exact_snippets": "Detectable viral load for HIV (human immunodeficiency virus)",
"criterion": "HIV viral load",
"requirements": [
{
"requirement_type": "detectability",
"expected_value": true
}
]
},
{
"exact_snippets": "Detectable viral load for hepatitis B",
"criterion": "hepatitis B viral load",
"requirements": [
{
"requirement_type": "detectability",
"expected_value": true
}
]
},
{
"exact_snippets": "Detectable viral load for ... hepatitis C",
"criterion": "hepatitis C viral load",
"requirements": [
{
"requirement_type": "detectability",
"expected_value": true
}
]
}
]
},
{
"line": "* Part 2: You can have cancer that has spread to your brain but there are exceptions. The cancer in your brain cannot be causing any symptoms, it cannot be larger than 3 cm, there can be no evidence on a scan that shows your brain tissue has shifted from its expected position inside the skull (called \"herniation\") or be bleeding in the skull or brain itself (called \"hemorrhage\").",
"criterions": [
{
"exact_snippets": "cancer that has spread to your brain",
"criterion": "cancer metastasis to brain",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "cancer in your brain cannot be causing any symptoms",
"criterion": "symptoms from brain metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "cancer in your brain cannot be larger than 3 cm",
"criterion": "size of brain metastasis",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": "<=",
"value": 3,
"unit": "cm"
}
}
]
},
{
"exact_snippets": "no evidence on a scan that shows your brain tissue has shifted from its expected position inside the skull (called \"herniation\")",
"criterion": "brain tissue herniation",
"requirements": [
{
"requirement_type": "evidence on scan",
"expected_value": false
}
]
},
{
"exact_snippets": "be bleeding in the skull or brain itself (called \"hemorrhage\")",
"criterion": "intracranial hemorrhage",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"failed_miscellaneous": [
{
"line": "Key",
"criterions": [
{
"exact_snippets": "Tissue from tumor must be available",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"exact_snippets": "Tissue from tumor ... > 2 cm in diameter.",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "size",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "cm"
}
}
]
}
]
}
]
}